Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dydrogesterone tablets versus progesterone suppositories for luteal phase support after ovulation induction
IRCT20260531069587N1Phase 3Completed
- Sponsor
- Vice Chancellor for Research, Birjand University of Medical Sciences
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in infertility comparing Dydrogesterone tablet arm with Progesterone suppository arm (2 arms). Primary endpoints: Efficacy comparison between progesterone tablets and suppositories, Tolerability and side effects and 2 more. Started Jun 2026; status: completed.
02
Drugs
dydrogesteroneprogesterone
03
Conditions
infertility
Beyond the preview
Go deeper on IRCT20260531069587N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260531069587N1.